{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:24:07Z","timestamp":1791869047642,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thoracic.theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.thorsurg.2016.04.011","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T15:00:19Z","timestamp":1468681219000},"page":"325-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Induction Therapy for Thymoma"],"prefix":"10.1016","volume":"26","author":[{"given":"Usman","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thorsurg.2016.04.011_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","article-title":"Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy","volume":"44","author":"de Jong","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A\u00a0review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib3","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/JTO.0000000000000269","article-title":"Development of the international thymic malignancy interest group international database: an unprecedented resource for the study of a rare group of tumors","volume":"9","author":"Huang","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.athoracsur.2015.04.059","article-title":"Surgical outcomes of patients with stage III thymoma in the Japanese nationwide database","volume":"100","author":"Yamada","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib5","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.athoracsur.2003.10.001","article-title":"Thymic tumors","volume":"77","author":"Detterbeck","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thorsurg.2010.08.001","article-title":"Management of stage I and II thymoma","volume":"21","author":"Detterbeck","year":"2011","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib7","doi-asserted-by":"crossref","first-page":"S1717","DOI":"10.1097\/JTO.0b013e31821e8cd6","article-title":"Standard report terms for chest computed tomography reports of anterior mediastinal masses suspicious for thymoma","volume":"6","author":"Marom","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/JTO.0b013e3182835549","article-title":"FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies","volume":"8","author":"Benveniste","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib9","doi-asserted-by":"crossref","first-page":"S1724","DOI":"10.1097\/JTO.0b013e31821ea57c","article-title":"Policies and reporting guidelines for small biopsy specimens of mediastinal masses","volume":"6","author":"Marchevsky","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","article-title":"Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group","volume":"14","author":"Giaccone","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","article-title":"Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report","volume":"44","author":"Kim","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjc.6605731","article-title":"A\u00a0phase II trial of dose-dense chemotherapy, followed by surgical resection and\/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)","volume":"103","author":"Kunitoh","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1556-0864(15)31586-0","article-title":"Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up","volume":"1","author":"Lucchi","year":"2006","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jtcvs.2015.08.034","article-title":"Multimodality therapy for locally advanced thymomas: a propensity score-matched cohort study from the European Society of Thoracic Surgeons Database","volume":"151","author":"Leuzzi","year":"2016","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1200\/JCO.2006.08.2826","article-title":"Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)","volume":"25","author":"Rusch","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib17","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib18","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","article-title":"Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial","volume":"15","author":"Loehrer","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2007.08.051","article-title":"Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors","volume":"85","author":"Wright","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtcvs.2013.08.061","article-title":"Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial","volume":"147","author":"Korst","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.athoracsur.2007.10.098","article-title":"Multimodality therapy for locally advanced thymomas: state of the art or investigational therapy?","volume":"85","author":"Huang","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0003-4975(95)00983-3","article-title":"Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded","volume":"61","author":"Yagi","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib23","first-page":"53","article-title":"Lympho-epithelial thymoma. Anatomo-clinical and therapeutic study of 113 cases","volume":"5","author":"Ribet","year":"1988","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1096-9098(199609)63:1<17::AID-JSO4>3.0.CO;2-T","article-title":"Preoperative radiotherapy and surgery for advanced thymoma with invasion to the great vessels","volume":"63","author":"Akaogi","year":"1996","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ejcts\/ezt649","article-title":"Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database","volume":"46","author":"Ruffini","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtcvs.2014.09.124","article-title":"Thymic carcinoma outcomes and prognosis: results of an international analysis","volume":"149","author":"Ahmad","year":"2015","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jtcvs.2012.10.013","article-title":"Resection and heated pleural chemoperfusion in patients with thymic epithelial malignant disease and pleural spread: a single-institution experience","volume":"145","author":"Yellin","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1510\/icvts.2010.255307","article-title":"Induction chemotherapy, cytoreductive surgery and intraoperative hyperthermic pleural irrigation in patients with stage IVA thymoma","volume":"12","author":"Belcher","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00432-001-0319-9","article-title":"Epidermal growth factor receptor expression in invasive thymoma","volume":"128","author":"Henley","year":"2002","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib30","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","article-title":"Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas","volume":"15","author":"Girard","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib31","doi-asserted-by":"crossref","first-page":"381s","DOI":"10.1200\/jco.2005.23.16_suppl.7068","article-title":"Phase II study of gefitinib treatment in advanced thymic malignancies","volume":"23","author":"Kurup","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl","key":"10.1016\/j.thorsurg.2016.04.011_bib32","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1200\/jco.2008.26.15_suppl.19087","article-title":"A\u00a0phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma","volume":"26","author":"Bedano","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib33","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/JTO.0b013e3181b6be57","article-title":"Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas","volume":"4","author":"Giaccone","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib34","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/JTO.0b013e3181e392a8","article-title":"Insulin-like growth factor-1 receptor expression in thymic malignancies","volume":"5","author":"Girard","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib35","unstructured":"Giaccone G. Multicenter phase II study of IMC-A12 in patients with thymoma and thymic carcinoma who have been previously treated with chemotherapy. NCT00965250. Available at: https:\/\/clinicaltrials.gov."},{"key":"10.1016\/j.thorsurg.2016.04.011_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1470-2045(13)70596-5","article-title":"Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial","volume":"15","author":"Rajan","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/1097-0142(19910815)68:4<706::AID-CNCR2820680407>3.0.CO;2-H","article-title":"Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma","volume":"68","author":"Macchiarini","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-5223(19)34092-9","article-title":"Chemotherapy and operation for invasive thymoma","volume":"106","author":"Rea","year":"1993","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/oxfordjournals.annonc.a058527","article-title":"Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients","volume":"4","author":"Berruti","year":"1993","journal-title":"Ann Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib40","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0003-4975(97)00629-2","article-title":"Multimodality treatment of thymoma: a prospective study","volume":"64","author":"Venuta","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/JTO.0b013e31802bafc8","article-title":"Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone","volume":"2","author":"Yokoi","year":"2007","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2016.04.011_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2003.09.022","article-title":"Multimodal management of stages III-IVa malignant thymoma","volume":"44","author":"Bretti","year":"2004","journal-title":"Lung Cancer"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412716300111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412716300111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T02:04:13Z","timestamp":1600913053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412716300111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1547412716300111"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2016.04.011","relation":{},"ISSN":["1547-4127"],"issn-type":[{"value":"1547-4127","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction Therapy for Thymoma","name":"articletitle","label":"Article Title"},{"value":"Thoracic Surgery Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thorsurg.2016.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}